Stephen Taub Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. Stephen Taub December 8, 2020 Jonne Roriz/Bloomberg